Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial (17/03/2023)
28 julio, 2023
Dra. Verónica Briz
Centro Nacional de Microbiología Instituto de Salud Carlos III.
